Patients with systemic autoimmune diseases could not distinguish comorbidities from their index disease

Journal of Clinical Epidemiology

Volumn 61, Issue 7, 2008, Pages 654-662

  Hudson, Marie ^a   Bernatsky, Sasha ^a   Taillefer, Suzanne ^a   Fortin, Paul R ^b   Wither, Joan ^b   Baron, Murray ^a  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Comorbidity; Construct validity; Self Administered Comorbidity Questionnaire; Systemic auto immune rheumatic diseases; Systemic lupus erythematosus; Systemic sclerosis

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; COMORBIDITY; CONSTRUCT VALIDITY; CONTROLLED STUDY; FEMALE; HUMAN; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; PATIENT ASSESSMENT; PRIORITY JOURNAL; PULMONARY HYPERTENSION; QUALITY OF LIFE; QUESTIONNAIRE; SCORING SYSTEM; SHORT FORM 36; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; AUTOIMMUNE DISEASES; CHRONIC DISEASE; COMORBIDITY; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; SCLERODERMA, SYSTEMIC; SICKNESS IMPACT PROFILE;

EID: 44649172529     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jclinepi.2007.08.010     Document Type: Article

References (39)

1. Feinstein A. The pre-therapeutic classification of co-morbidity in chronic disease. J Chronic Dis 23 (1970) 455-468
2. Greenfield S., Aronow H.U., Elashoff R.M., and Watanabe D. Flaws in mortality data. The hazards of ignoring comorbid disease. JAMA 260 (1988) 2253-2255
3. Charlson M.E., Pompei P., Ales K.L., and MacKenzie C.R. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40 (1987) 373-383
4. Guralnik J., LaCroix A., Everett D., and Kovar M. Aging in the eighties: the prevalence of comorbidity and its association with disability. Advance data from vital and health statistics (1989), National Centre for Health Statistics, Hyattsville, MD
5. Wolff J.L., Starfield B., and Anderson G. Prevalence, expenditures, and complications of multiple chronic conditions in the elderly. Arch Intern Med 162 (2002) 2269-2276
6. Hoffman C., Rice D., and Sung H.Y. Persons with chronic conditions. Their prevalence and costs. JAMA 276 (1996) 1473-1479
7. Fortin M., Lapointe L., Hudon C., Vanasse A., Ntetu A.L., and Maltais D. Multimorbidity and quality of life in primary care: a systematic review. Health Qual Life Outcomes 2 (2004) 51
8. Greenfield S., Apolone G., McNeil B.J., and Cleary P.D. The importance of co-existent disease in the occurrence of postoperative complications and one-year recovery in patients undergoing total hip replacement. Comorbidity and outcomes after hip replacement. Med Care 31 (1993) 141-154
9. Concato J., Horwitz R.I., Feinstein A.R., Elmore J.G., and Schiff S.F. Problems of comorbidity in mortality after prostatectomy. JAMA 267 (1992) 1077-1082
10. Rubin H.R., and Wu A.W. The risk of adjustment. Med Care 30 (1992) 973-975
11. Linet M.S., Harlow S.D., McLaughlin J.K., and McCaffrey L.D. A comparison of interview data and medical records for previous medical conditions and surgery. J Clin Epidemiol 42 (1989) 1207-1213
12. Katz J.N., Chang L.C., Sangha O., Fossel A.H., and Bates D.W. Can comorbidity be measured by questionnaire rather than medical record review?. Med Care 34 (1996) 73-84
13. Kriegsman D.M., Penninx B.W., van Eijk J.T., Boeke A.J., and Deeg D.J. Self-reports and general practitioner information on the presence of chronic diseases in community dwelling elderly. A study on the accuracy of patients' self-reports and on determinants of inaccuracy. J Clin Epidemiol 49 (1996) 1407-1417
14. Sangha O., Stucki G., Liang M.H., Fossel A.H., and Katz J.N. The Self-Administered Comorbidity Questionnaire: a new method to assess comorbidity for clinical and health services research. Arthritis Rheum 49 (2003) 156-163
15. Stier D.M., Greenfield S., Lubeck D.P., Dukes K.A., Flanders S.C., Henning J.M., et al. Quantifying comorbidity in a disease-specific cohort: adaptation of the total illness burden index to prostate cancer. Urology 54 (1999) 424-429
16. Hayward R.A., Manning W.G., Kaplan S.H., Wagner E.H., and Greenfield S. Starting insulin therapy in patients with type 2 diabetes: effectiveness, complications, and resource utilization. JAMA 278 (1997) 1663-1669
17. Clements P.J., Lachenbruch P.A., Seibold J.R., White B., Weiner S., Martin R., et al. Skin thickness score in systemic sclerosis: an assessment of interobserver variability in 3 independent studies. J Rheumatol 20 (1993) 1892-1896
18. Van Tubergen A., Debats I., Ryser L., Londoño J., Burgos-Vargas R., Cardiel M.H., et al. Use of a numerical rating scale as an answer modality in ankylosing spondylitis-specific questionnaires. Arthritis Rheum 47 (2002) 242-248
19. Ferraz M.B., Quaresma M.R., Aquino L.R., Atra E., Tugwell P., and Goldsmith C.H. Reliability of pain scales in the assessment of literate and illiterate patients with rheumatoid arthritis. J Rheumatol 17 (1990) 1022-1024
20. Fries J.F., Spitz P., Kraines R.G., and Holman H.R. Measurement of patient outcome in arthritis. Arthritis Rheum 23 (1980) 137-145
21. Steen V.D., and Medsger Jr. T.A. The value of the Health Assessment Questionnaire and special patient-generated scales to demonstrate change in systemic sclerosis patients over time. Arthritis Rheum 40 (1997) 1984-1991
22. Valentini G., Della Rossa A., Bombardieri S., Bencivelli W., Silman A.J., D'Angelo S., et al. European multicentre study to define disease activity criteria for systemic sclerosis. II. Identification of disease activity variables and development of preliminary activity indexes. Ann Rheum Dis 60 (2001) 592-598
23. Valentini G., Bencivelli W., Bombardieri S., D'Angelo S., Della Rossa A., Silman A.J., et al. European Scleroderma Study Group to define disease activity criteria for systemic sclerosis. III. Assessment of the construct validity of the preliminary activity criteria. Ann Rheum Dis 62 (2003) 901-903
24. Medsger Jr. T.A., Silman A.J., Steen V.D., Black C.M., Akesson A., Bacon P.A., et al. A disease severity scale for systemic sclerosis: development and testing. J Rheumatol 26 10 (1999) 2159-2167
25. Medsger Jr. T.A., Bombardieri S., Czirjak L., Scorza R., Della Rossa A., and Bencivelli W. Assessment of disease severity and prognosis. Clin Exp Rheumatol 21 3 Suppl. 29 (2003) S42-S46
26. Medical Research Council. Aids to the examination of the peripheral nervous system. Memorandum no. 45 (1976), Her Majesty's Stationary FOffice
27. Abrahamowicz M., Fortin P.R., du Berger R., Nayak V., Neville C., and Liang M.H. The relationship between disease activity and expert physician's decision to start major treatment in active systemic lupus erythematosus: a decision aid for development of entry criteria for clinical trials. J Rheumatol 25 (1998) 277-284
28. Gladman D.D., Ibanez D., and Urowitz M.B. Systemic lupus erythematosus disease activity index 2000. J Rheumatol 29 (2002) 288-291
29. Gladman D., Ginzler E., Goldsmith C., Fortin P., Liang M., Urowitz M., et al. The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 39 (1996) 363-369
30. Ware Jr. J.E., and Sherbourne C.D. The MOS 36 item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 30 (1992) 473-483
31. Ware J.J., Snow K., Kosinski M., and Gandek B. SF-36 Health Survey: Manual and interpretation guide (1993), The Health Institute, New England Medical Center, Boston, MA
32. Guillemin F., Bombardier C., and Beaton D. Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines. J Clin Epidemiol 46 (1993) 1417-1432
33. Streiner D., and Norman G. Health measurement scales-A practical guide to their development and use. 2nd edition (1996), Oxford University Press, Oxford
34. Schneeweiss S., and Maclure M. Use of comorbidity scores for control of confounding in studies using administrative databases. Int J Epidemiol 29 (2000) 891-898
35. Khanna D., Clements P.J., Furst D.E., Chon Y., Elashoff R., Roth M.D., et al. Correlation of the degree of dyspnea with health-related quality of life, functional abilities, and diffusing capacity for carbon monoxide in patients with systemic sclerosis and active alveolitis: results from the Scleroderma Lung Study. Arthritis Rheum 52 (2005) 592-600
36. van den Akker M., Buntinx F., Metsemakers J.F., Roos S., and Knottnerus J.A. Multimorbidity in general practice: prevalence, incidence, and determinants of co-occurring chronic and recurrent diseases. J Clin Epidemiol 51 (1998) 367-375
37. de Groot V., Beckerman H., Lankhorst G.J., and Bouter L.M. How to measure comorbidity. A critical review of available methods. J Clin Epidemiol 56 (2003) 221-229
38. Ward M.M. Development and testing of a systemic lupus-specific risk adjustment index for in-hospital mortality. J Rheumatol 27 (2000) 1408-1413
39. Ward M.M., Pajevic S., Dreyfuss J., and Malley J.D. Short-term prediction of mortality in patients with systemic lupus erythematosus: classification of outcomes using random forests. Arthritis Rheum 55 (2006) 74-80